Appointment
Gannet BioChem Names Nicholas Shackley as Chief Executive Officer, Announces Leadership Team Expansion
Gannet BioChem
PR-03-25-NI-05Mar 11, 2025
Acquisition
Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem
Ampersand Capital Partners
PR-12-24-NI-121Dec 02, 2024